25
Participants
Start Date
May 25, 2021
Primary Completion Date
January 3, 2022
Study Completion Date
January 3, 2022
Beclomethasone dipropionate/Formoterol Fumarate/Glycopyrronium
Two inhalations bid: 4 inhalations; total daily dose of 400/24/50 μg BDP/FF/GB
OLV Hospital Aalst, Aalst
Centre medical Erpent - Residence, Erpent
AZ Zeno Knokke-Heist, Knokke
Heilige Familie AZ, Reet
AZ Delta, Roeselare
Dr. Kenessey Albert Hospital, Balassagyarmat
National Koranyi Institute for TB and Pulmonology, Budapest
CRU Hungary Ltd, Miskolc
Chiesi Farmaceutici S.p.A.
INDUSTRY